Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy
Clinical trial NCT01751776 · COMPLETED
Trial details
- NCT number
- NCT01751776
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-18
- Primary completion
- 2015-03-02
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.